Pharmafile Logo

Piramal | Healthcare

Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise. We are one of the largest custom manufacturing companies in the world that provides flexibility and scalability of operations. We have created a vast network of contract development and manufacturing facilities located in North America, Europe and Asia that offers a multitude of services that cover the entire drug-cycle, from development and commercial manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. Our network enables us to deliver benefits by strategically placing projects to take advantage of low costs, local supply chains and specific customer/ market requirements. This division features among the top 10 contract drug manufacturers in the world.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

247 Business Park, A - Wing, 6th Floor, LBS Marg, Vikhroli (West), Mumbai, Maharashtra, 400083, India
022-30956893

 Latest Content from PMHub 

The future of heart health with AI-powered devices and treatment approaches

Artificial intelligence (AI) is revolutionising the field of cardiology, offering new hope for patients with cardiovascular disorders. AI is no longer futuristic, it’s a real-world tool, transforming patient care and...

The Cat’s Out of the Bag… Kim Walker, ex-GCI Health, Joins Fox&Cat as Partner and Managing Director

Press Releases | March 26, 2025 | Fox&Cat

Fox&Cat appoints Kim Walker as Partner and Managing Director, bringing leadership strength and operational focus to the agency. Her arrival enhances Fox&Cat’s ADAPT™ methodology and consultancy model, reinforcing its commitment...

Live Q&A: Beyond NHS England – Restructuring and its implications for Pharma and Medtech

What does the abolition of NHS England mean for your market access and NHS Engagement strategy? How will the changes at national and integrated care board (ICB) level impact launch...

Medscape at ACC 2025: From Taking the Pulse to Getting to the Heart of It

The Medscape team is back in Chicago for the much-anticipated ACC 2025 conference,  March 29-31, bringing an array of engaging educational booth highlights, interactive symposia, scientific posters, and more for...

Web Design Strategies for Pharma & Life Sciences in 2025

As we approach 2025, healthcare and life sciences SMEs face an increasingly digital world. A seamless, mobile-friendly website that harnesses AI-driven personalisation and intuitive design elements isn’t just a luxury...

Leveraging the ABPI QR Code Update: Enhancing Prescribing Information Through Best Practices

ABPI's recent update permits QR codes in printed pharmaceutical materials for prescribing information. By ensuring visibility, providing clear instructions, linking directly, and keeping content current, companies can enhance accessibility, ensure...

Pi 360 – A Smarter, Automated Solution for Digital Prescribing Information (PI) & QR Code Compliance

Press Releases | March 21, 2025 | Genetic Digital

Life sciences digital agency Genetic Digital has launched Pi 360, a cutting-edge web application designed to help pharmaceutical companies automate the creation, management and distribution of Prescribing Information (PI) while...

Hidden in Plain Sight: The Compliance Risks of Search Engine Indexed Pharma Content

Pharma companies must balance HCP access and MHRA/ABPI compliance by preventing public search indexing of promotional prescription medicine content.

Boost Publication Collaboration Virtually – Engaging Your Advisors Creatively

Tired of traditional advisory board limitations? Explore innovative ways to engage your KOLs, HCPs, and MSLs in our new series! Learn how to co-create impactful publications virtually in our first...

Communicating value to US Payers: Insights for Pharma and Medtech

What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging...